More and more women are giving birth by caesarean section. The procedure accounted for 21.1% of global births in 2021 and is forecast to reach 29.0% by 2030. In the English NHS the current rate of caesareans is, at 41.4%, much higher than the global average and is increasing steadily every year.
While caesarean sections are generally safe, like any surgery they carry risks – of which surgical site infection (SSI) is the most common. Although most infections are superficial and occur after discharge from hospital, they can still incur significant costs due to extended community midwife visits, GP visits and antibiotic prescribing. Deeper and more severe infections can require extended hospital stays or readmission, increasing the burden on maternity services and workforces that may already be under significant pressure.
One way that maternity services are helping reduce infections is by implementing a ‘bundle’ of evidence-based practices that clinical trials have shown to be effective. These practices can include antibiotic prophylaxis, antiseptic skin preparation and closing the skin with subcutaneous sutures instead of staples.
A less well known but very effective intervention for reducing infections is glove change. A recent systematic review and meta-analysis has demonstrated that obstetric teams that change their gloves after placental delivery and before wound closure can achieve a 59 per cent reduction in the incidence of post-caesarean SSI. In my latest study I’ve collaborated with Health Innovation West of England, Royal United Hospitals Bath NHS Foundation Trust and Mölnlycke Health Care to analyse the impact this could have on the budget and capacity of a typical NHS maternity service and on the English NHS as a whole, if it was adopted as a standard practice.
Our budget impact analysis showed us that:
Neither the World Health Organization nor NICE – National Institute for Health and Care Excellence presently recommend changing gloves before wound closure. But given that caesarean sections are more expensive and have worse perinatal outcomes than natural births, shouldn’t this now change? Can glove change enable obstetric teams to deliver more value-based care?
That’s a question we’ll be discussing when we present our results at the upcoming Annual Congress of the Surgical Infection Society Europe, taking place in Dublin from 14 – 16 May. Come and join us there or download a copy of our presentation to discover more.
This study was undertaken by Benedict Stanberry, Lesley Jordan, Anne Pullyblank and Judith Hargreaves. It was supported by a financial grant from Mölnlycke Health Care AB.
Health Economic Modelling
A practical, hands-on course on how to design, build and present budget impact models for health technology assessments, business cases and value propositions using Excel.
Patient Experience
A comprehensive course for progressive healthcare providers and professionals who want to design and deliver more person-centred, compassionate and responsive care.
Health Technology Assessment
This course will enable you and your healthcare organisation to achieve operational excellence by improving capacity, productivity and patient flow at every stage of care.
Value Communication
This course will enable you to master the concepts, methods and tools you need to lead successful quality improvement projects or become a quality improvement specialist.
HEOR Strategy
This course enables you to plan, design and manage the clinical and economic evidence needed to support market access, reimbursement and health technology assessment.
Healthcare Leadership
Our flagship course for high-potential healthcare leaders: built around the core strategic management disciplines and designed to prepare you for more senior roles and greater responsibilities.
Real-World Evidence
A practical course that equips you to design, conduct, analyse and appraise observational studies that generate credible evidence for HTA bodies and payers.
Evidence Review and Synthesis
A practical course that will enable you to compile, appraise and summarise existing research using the “gold standard” in evidence-based decision-making.
HEOR Strategy
Discover how artificial intelligence is reshaping health economics and outcomes research — and what it means for the professionals who commission and undertake this work.
Value Communication
Discover how to transform clinical, economic and outcomes evidence into a compelling value story that convinces decision-makers and accelerates market access.
Health Technology Assessment
This case study-based course introduces you to the fundamentals of health technology assessment and how to get submissions right first time.
Health Economic Modelling
This hands-on course shows you how to build, interpret and present cost-effectiveness and cost-utility models that measure the value of health interventions and guide healthcare decision-making.
Evidence Review and Synthesis
Discover how to plan, commission and evaluate rapid evidence reviews that generate accelerated, evidence-based insights in response to time-sensitive demands.
August 11, 2026
A systematic review of orphan drug budget impact analyses found most fall short of ISPOR good practice guidelines. So what separates a rigorous budget impact analysis from the rest?
February 13, 2026
Introducing yourself properly is surely a basic necessity if we’re to be a respectful and trusted caregiver?
Course starts: 02 September 2026
Location: Online
Course starts: 02 September 2026
Location: Online